MktsMarkets

Corcept Therapeutics Incorporated
NASDAQ: CORTKey statistics
CORT News
Stories mentioning CORT from around the web — every one is an open thread, so give it a like or add your take.
Loading news…
Financial statements
As filed, straight from the 10-Q — up to 19 years of history, free, with every line item chartable.
| Line item | Q1 '26Mar 31 | Q4 '25Dec 31 | Q3 '25Sep 30 | Q2 '25Jun 30 | Q1 '25Mar 31 | Q4 '24Dec 31 | Q3 '24Sep 30 | Q2 '24Jun 30 |
|---|---|---|---|---|---|---|---|---|
| Income Statement | ||||||||
| Revenue | 164,903 | 202,125 | 207,638 | 194,430 | 157,214 | 181,890 | 182,546 | 163,796 |
| Cost of Goods Sold | 2,883 | 2,545 | 4,596 | 3,433 | 2,403 | 2,956 | 2,867 | 2,524 |
| Gross Profit | 162,020 | 199,580 | 203,042 | 190,997 | 154,811 | 178,934 | 179,679 | 161,272 |
| Operating Expenses | ||||||||
| Research & Development | 66,265 | 64,856 | 68,846 | 60,471 | 60,735 | 70,301 | 59,336 | 58,745 |
| Sales General & Admin | 145,356 | 130,237 | 123,977 | 103,851 | 90,660 | 83,372 | 73,745 | 66,935 |
| Total Operating Expenses | ||||||||
| Operating Income (Loss) | (49,601) | 4,487 | 10,219 | 26,675 | 3,416 | 25,261 | 46,598 | 35,592 |
| Interest Income | ||||||||
| Interest Expense | ||||||||
| Other Expense | ||||||||
| Pretax Income | (44,715) | 9,910 | 15,243 | 31,692 | 9,618 | 31,961 | 52,943 | 41,596 |
| Tax Provision | (12,954) | (14,378) | (4,425) | (3,457) | (10,929) | 1,215 | 5,730 | 6,108 |
| Net Income (Loss) | (31,761) | 24,288 | 19,668 | 35,149 | 20,547 | 30,746 | 47,213 | 35,488 |
| Earnings Per Share (Basic) | (0.30) | 0.23 | 0.19 | 0.33 | 0.19 | 0.30 | 0.45 | 0.34 |
| Earnings Per Share (Diluted) | (0.30) | 0.20 | 0.16 | 0.29 | 0.17 | 0.27 | 0.41 | 0.32 |
| Weighted Average Shares Outstanding (Basic) | 104,435 | 103,862 | 103,545 | 104,111 | 104,106 | 103,232 | 103,371 | 103,118 |
| Weighted Average Shares Outstanding (Diluted) | 104,435 | 119,987 | 119,439 | 120,485 | 119,819 | 113,480 | 113,723 | 111,244 |
Scroll the table sideways for older periods — the line-item column and the period header stay put. Hover a row and use the chart handle to plot it over the full history.
About CORT
Corcept Therapeutics Incorporated (NASDAQ: CORT) is a stock listed on the Nasdaq Stock Market under the ticker symbol CORT. It last traded at $67.79 (Nov 18, 2026, 4:00 PM ET), down 3.3% on the day. That gives Corcept Therapeutics a market capitalisation of $7.7B and a price-to-earnings ratio of 47.3.
Over the past 52 weeks CORT has traded between $28.66 and $126.38.
Revenue for the quarter ended Mar 31, 2026 was $164.9M; a net loss of $31.8M. Revenue was up 4.9% from $157.2M in the quarter ended Mar 31, 2025.
| Quarter ended | Revenue | Net income | Margin |
|---|---|---|---|
| Mar 31, 2026 | $164.9M | -$31.8M | -19.3% |
| Dec 31, 2025 | $202.1M | $24.3M | 12.0% |
| Sep 30, 2025 | $207.6M | $19.7M | 9.5% |
| Jun 30, 2025 | $194.4M | $35.1M | 18.1% |
From Corcept Therapeutics’s quarterly (10-Q) filings, in US dollars.
Take a break — play a market game
Seven free games built around the markets. No download, no sign-up: they run right here in your browser.
Latest News
Market news from around the web — every story is an open thread, so give it a like or add your take.
Loading news…